Blueprint Medicines Corp (FRA:2L9)
€ 95.7 0.66 (0.69%) Market Cap: 5.92 Bil Enterprise Value: 5.63 Bil PE Ratio: 0 PB Ratio: 20.69 GF Score: 72/100

Blueprint Medicines Corp (FRA:2L9) Transcripts

  • 1